Bullock Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03K Hold
42
– – ﹤0.01% 574
2026
Q1
$592 Hold
42
– – ﹤0.01% 595
2025
Q4
$472 Hold
42
– – ﹤0.01% 588
2025
Q3
$480 Hold
42
– – ﹤0.01% 603
2025
Q2
$526 Hold
42
– – ﹤0.01% 564
2025
Q1
$603 Hold
42
– – ﹤0.01% 550
2024
Q4
$669 Hold
42
– – ﹤0.01% 570
2024
Q3
$990 Hold
42
– – ﹤0.01% 530
2024
Q2
$828 Hold
42
– – ﹤0.01% 528
2024
Q1
$823 Buy
+42
New +$812 ﹤0.01% 527

Other funds holding AVNS

Bullock Wealth Management's AVNS Position: Q2 2026 in Review

Bullock Wealth Management held its Avanos Medical (AVNS) position steady in Q2 2026 at 42 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Bullock Wealth Management first reported a position in AVNS in Q1 2024 and has held it in 10 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Bullock Wealth Management held 42 shares of Avanos Medical worth $1.03K as of Q2 2026.
  • Bullock Wealth Management left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #574 holding.
  • Bullock Wealth Management first reported a position in Avanos Medical in Q1 2024 and has held it in 10 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.